Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,318 GBX | -0.42% | +1.65% | +16.21% |
06:44pm | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
06:39pm | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.21% | 24TCr | |
+29.46% | 68TCr | |
+30.34% | 57TCr | |
-3.94% | 36TCr | |
+17.66% | 33TCr | |
+4.01% | 28TCr | |
+9.66% | 21TCr | |
-6.83% | 20TCr | |
+6.96% | 17TCr | |
-1.37% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca's Partner Daiichi Sankyo Says Enhertu Meets Objective Response Rate Target in Solid Tumors Phase 2 Trial